miR-10a |
Inhibit Hoxd4 to control cancer metastasis |
Breast cancer cell lines: MCF7 and MDA-MB-231 |
[39] |
miR-483 |
Activate IGF2 to enhance tumorigenesis |
Wilms’ tumors |
[59] |
miR-558 |
Activate HPSE to promote tumor growth |
Neuroblastoma cell lines: SK-N-SH, SK-N-AS, SH-SY5Y and SK-N-BE(2) |
[44] |
miR-373 |
Increase expression of CDH1 tumor suppressor gene |
Prostate cancer cell line: PC3 |
[38] |
miR-124 |
Activate tumor suppressor gene, P27
|
Breast and ovarian cancer cell lines: MDA-MB-231, HeyA8, SKOV3.ip1, SKBr3, OVCAR-3, BxPC-3 and L3.6pl, MIA PaCa 2, Panc1, U87, SNB19 and LN229 |
[60]. |
miR-205 |
Activate interleukin tumor suppressor genes, IL24 and IL32
|
Prostate cancer cell lines: PC3, LNCaP and Du145 |
[45]. |
miR-774 |
Promote transcription of Ccnb1
|
Mouse prostate adenocarcinoma cell line: TRAMP C1 |
[61] |
miR-370 |
Activate tumor suppressor gene, P21
|
Bladder cancer cell lines: T24 and EJ |
[76] |
miR-1180 |
Activate tumor suppressor gene, P21
|
Bladder cancer cell lines: T24 and EJ |
[76] |
miR-1236 |
Activate tumor suppressor gene, P21
|
Bladder cancer cell lines: T24 and EJ |
[76] |
miR-939 |
Repression of Bcl-xl anti-apoptosis gene |
Human neuroblastoma cell line: SH-SY5Y |
[62] |